Skip to main content
Premium Trial:

Request an Annual Quote

Dante Labs Acquires Cambridge Cancer Genomics

NEW YORK — Dante Labs said on Wednesday that it has acquired UK-based cancer informatics firm Cambridge Cancer Genomics, or CCG, for an undisclosed amount.

Additional terms of the deal were not disclosed.

According to New York City-based Dante Labs, the acquisition will bring together its CE-IVD-marked Immensa Genomics Interpretation Software, which enables the interpretation of whole-genome sequencing data in a clinical setting, with CCG's artificial intelligence-based OncOS precision oncology software.

About a year ago, Dante Labs and CCG began working together with Nonacus to build a high-throughput cancer sequencing and interpretation service for tumor profiling.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.